Civil society representatives at the WHO Regional Committee for Africa warned that medical advances against HIV remain inaccessible to patients in developing countries because of high prices. Sub-saharan Africa, which bears a disproportionate burden of the HIV epidemic, remains most at risk.
The civil society representatives from HAI Africa, OXFAM and TB Action observed that an increasing number of essential medicines are being patented in developing countries and such patents were an obstacle to price reductions. This undermines access because high prices place medicines outside the reach of poor people and governments.
Health Action International (HAI) Africa and Oxfam have warned that the growing push to enact anti-counterfeit laws could undermine access to affordable medicines in Africa. They point to a disturbing trend on confiscation of generic medicines on the pretext of cracking down on counterfeits.
HAI Africa and Oxfam have decried confusion in the development and enforcement of anti-counterfeit legislation, which has resulted in consignments of generic medicines being labelled counterfeits.



Access to essential medicines remains a major challenge in most African countries. For the majority of Africans, essential medicines remain largely unavailable and inaccessible.